Global LV-Based Cell and Gene Therapy Products Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 91

Published Date: 07 Apr 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.

According to our (Global Info Research) latest study, the global LV-Based Cell and Gene Therapy Products market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global LV-Based Cell and Gene Therapy Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global LV-Based Cell and Gene Therapy Products market size and forecasts, in consumption value ($ Million), 2019-2030
Global LV-Based Cell and Gene Therapy Products market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global LV-Based Cell and Gene Therapy Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global LV-Based Cell and Gene Therapy Products market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for LV-Based Cell and Gene Therapy Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global LV-Based Cell and Gene Therapy Products market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, Orchard Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
LV-Based Cell and Gene Therapy Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
LV-Based Cell and Gene Therapy Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    CAR-T Therapy
    Autologous CD34+ Cell Gene Therapy

Market segment by Application
    Hospital
    Diagnostic and Testing Laboratories
    Academic and Research Organizations
    Others

Market segment by players, this report covers
    Novartis
    Bluebird Bio
    Thermo Fisher Scientific
    Intas
    BMS
    Orchard Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe LV-Based Cell and Gene Therapy Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of LV-Based Cell and Gene Therapy Products, with revenue, gross margin, and global market share of LV-Based Cell and Gene Therapy Products from 2019 to 2024.
Chapter 3, the LV-Based Cell and Gene Therapy Products competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and LV-Based Cell and Gene Therapy Products market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of LV-Based Cell and Gene Therapy Products.
Chapter 13, to describe LV-Based Cell and Gene Therapy Products research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of LV-Based Cell and Gene Therapy Products by Type
        1.3.1 Overview: Global LV-Based Cell and Gene Therapy Products Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type in 2023
        1.3.3 CAR-T Therapy
        1.3.4 Autologous CD34+ Cell Gene Therapy
    1.4 Global LV-Based Cell and Gene Therapy Products Market by Application
        1.4.1 Overview: Global LV-Based Cell and Gene Therapy Products Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Diagnostic and Testing Laboratories
        1.4.4 Academic and Research Organizations
        1.4.5 Others
    1.5 Global LV-Based Cell and Gene Therapy Products Market Size & Forecast
    1.6 Global LV-Based Cell and Gene Therapy Products Market Size and Forecast by Region
        1.6.1 Global LV-Based Cell and Gene Therapy Products Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global LV-Based Cell and Gene Therapy Products Market Size by Region, (2019-2030)
        1.6.3 North America LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
        1.6.4 Europe LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
        1.6.6 South America LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis LV-Based Cell and Gene Therapy Products Product and Solutions
        2.1.4 Novartis LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Bluebird Bio
        2.2.1 Bluebird Bio Details
        2.2.2 Bluebird Bio Major Business
        2.2.3 Bluebird Bio LV-Based Cell and Gene Therapy Products Product and Solutions
        2.2.4 Bluebird Bio LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Bluebird Bio Recent Developments and Future Plans
    2.3 Thermo Fisher Scientific
        2.3.1 Thermo Fisher Scientific Details
        2.3.2 Thermo Fisher Scientific Major Business
        2.3.3 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product and Solutions
        2.3.4 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.4 Intas
        2.4.1 Intas Details
        2.4.2 Intas Major Business
        2.4.3 Intas LV-Based Cell and Gene Therapy Products Product and Solutions
        2.4.4 Intas LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Intas Recent Developments and Future Plans
    2.5 BMS
        2.5.1 BMS Details
        2.5.2 BMS Major Business
        2.5.3 BMS LV-Based Cell and Gene Therapy Products Product and Solutions
        2.5.4 BMS LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 BMS Recent Developments and Future Plans
    2.6 Orchard Therapeutics
        2.6.1 Orchard Therapeutics Details
        2.6.2 Orchard Therapeutics Major Business
        2.6.3 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product and Solutions
        2.6.4 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Orchard Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global LV-Based Cell and Gene Therapy Products Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of LV-Based Cell and Gene Therapy Products by Company Revenue
        3.2.2 Top 3 LV-Based Cell and Gene Therapy Products Players Market Share in 2023
        3.2.3 Top 6 LV-Based Cell and Gene Therapy Products Players Market Share in 2023
    3.3 LV-Based Cell and Gene Therapy Products Market: Overall Company Footprint Analysis
        3.3.1 LV-Based Cell and Gene Therapy Products Market: Region Footprint
        3.3.2 LV-Based Cell and Gene Therapy Products Market: Company Product Type Footprint
        3.3.3 LV-Based Cell and Gene Therapy Products Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global LV-Based Cell and Gene Therapy Products Consumption Value and Market Share by Type (2019-2024)
    4.2 Global LV-Based Cell and Gene Therapy Products Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application (2019-2024)
    5.2 Global LV-Based Cell and Gene Therapy Products Market Forecast by Application (2025-2030)

6 North America
    6.1 North America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
    6.2 North America LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2030)
    6.3 North America LV-Based Cell and Gene Therapy Products Market Size by Country
        6.3.1 North America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
        6.3.2 United States LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        6.3.3 Canada LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        6.3.4 Mexico LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
    7.2 Europe LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
    7.3 Europe LV-Based Cell and Gene Therapy Products Market Size by Country
        7.3.1 Europe LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
        7.3.2 Germany LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        7.3.3 France LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        7.3.5 Russia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        7.3.6 Italy LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific LV-Based Cell and Gene Therapy Products Market Size by Region
        8.3.1 Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Region (2019-2030)
        8.3.2 China LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        8.3.3 Japan LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        8.3.4 South Korea LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        8.3.5 India LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        8.3.7 Australia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

9 South America
    9.1 South America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
    9.2 South America LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
    9.3 South America LV-Based Cell and Gene Therapy Products Market Size by Country
        9.3.1 South America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
        9.3.2 Brazil LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        9.3.3 Argentina LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Country
        10.3.1 Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2030)
        10.3.2 Turkey LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)
        10.3.4 UAE LV-Based Cell and Gene Therapy Products Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 LV-Based Cell and Gene Therapy Products Market Drivers
    11.2 LV-Based Cell and Gene Therapy Products Market Restraints
    11.3 LV-Based Cell and Gene Therapy Products Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 LV-Based Cell and Gene Therapy Products Industry Chain
    12.2 LV-Based Cell and Gene Therapy Products Upstream Analysis
    12.3 LV-Based Cell and Gene Therapy Products Midstream Analysis
    12.4 LV-Based Cell and Gene Therapy Products Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global LV-Based Cell and Gene Therapy Products Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global LV-Based Cell and Gene Therapy Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global LV-Based Cell and Gene Therapy Products Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global LV-Based Cell and Gene Therapy Products Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Novartis Company Information, Head Office, and Major Competitors
 Table 6. Novartis Major Business
 Table 7. Novartis LV-Based Cell and Gene Therapy Products Product and Solutions
 Table 8. Novartis LV-Based Cell and Gene Therapy Products Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Novartis Recent Developments and Future Plans
 Table 10. Bluebird Bio Company Information, Head Office, and Major Competitors
 Table 11. Bluebird Bio Major Business
 Table 12. Bluebird Bio LV-Based Cell and Gene Therapy Products Product and Solutions
 Table 13. Bluebird Bio LV-Based Cell and Gene Therapy Products Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Bluebird Bio Recent Developments and Future Plans
 Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
 Table 16. Thermo Fisher Scientific Major Business
 Table 17. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product and Solutions
 Table 18. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Intas Company Information, Head Office, and Major Competitors
 Table 20. Intas Major Business
 Table 21. Intas LV-Based Cell and Gene Therapy Products Product and Solutions
 Table 22. Intas LV-Based Cell and Gene Therapy Products Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Intas Recent Developments and Future Plans
 Table 24. BMS Company Information, Head Office, and Major Competitors
 Table 25. BMS Major Business
 Table 26. BMS LV-Based Cell and Gene Therapy Products Product and Solutions
 Table 27. BMS LV-Based Cell and Gene Therapy Products Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. BMS Recent Developments and Future Plans
 Table 29. Orchard Therapeutics Company Information, Head Office, and Major Competitors
 Table 30. Orchard Therapeutics Major Business
 Table 31. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product and Solutions
 Table 32. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Orchard Therapeutics Recent Developments and Future Plans
 Table 34. Global LV-Based Cell and Gene Therapy Products Revenue (USD Million) by Players (2019-2024)
 Table 35. Global LV-Based Cell and Gene Therapy Products Revenue Share by Players (2019-2024)
 Table 36. Breakdown of LV-Based Cell and Gene Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 37. Market Position of Players in LV-Based Cell and Gene Therapy Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 38. Head Office of Key LV-Based Cell and Gene Therapy Products Players
 Table 39. LV-Based Cell and Gene Therapy Products Market: Company Product Type Footprint
 Table 40. LV-Based Cell and Gene Therapy Products Market: Company Product Application Footprint
 Table 41. LV-Based Cell and Gene Therapy Products New Market Entrants and Barriers to Market Entry
 Table 42. LV-Based Cell and Gene Therapy Products Mergers, Acquisition, Agreements, and Collaborations
 Table 43. Global LV-Based Cell and Gene Therapy Products Consumption Value (USD Million) by Type (2019-2024)
 Table 44. Global LV-Based Cell and Gene Therapy Products Consumption Value Share by Type (2019-2024)
 Table 45. Global LV-Based Cell and Gene Therapy Products Consumption Value Forecast by Type (2025-2030)
 Table 46. Global LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2024)
 Table 47. Global LV-Based Cell and Gene Therapy Products Consumption Value Forecast by Application (2025-2030)
 Table 48. North America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2024) & (USD Million)
 Table 49. North America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2025-2030) & (USD Million)
 Table 50. North America LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2024) & (USD Million)
 Table 51. North America LV-Based Cell and Gene Therapy Products Consumption Value by Application (2025-2030) & (USD Million)
 Table 52. North America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 53. North America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 54. Europe LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2024) & (USD Million)
 Table 55. Europe LV-Based Cell and Gene Therapy Products Consumption Value by Type (2025-2030) & (USD Million)
 Table 56. Europe LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2024) & (USD Million)
 Table 57. Europe LV-Based Cell and Gene Therapy Products Consumption Value by Application (2025-2030) & (USD Million)
 Table 58. Europe LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 59. Europe LV-Based Cell and Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 60. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2024) & (USD Million)
 Table 61. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Type (2025-2030) & (USD Million)
 Table 62. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2024) & (USD Million)
 Table 63. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Application (2025-2030) & (USD Million)
 Table 64. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Region (2019-2024) & (USD Million)
 Table 65. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value by Region (2025-2030) & (USD Million)
 Table 66. South America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2024) & (USD Million)
 Table 67. South America LV-Based Cell and Gene Therapy Products Consumption Value by Type (2025-2030) & (USD Million)
 Table 68. South America LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2024) & (USD Million)
 Table 69. South America LV-Based Cell and Gene Therapy Products Consumption Value by Application (2025-2030) & (USD Million)
 Table 70. South America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 71. South America LV-Based Cell and Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 72. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Type (2019-2024) & (USD Million)
 Table 73. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Type (2025-2030) & (USD Million)
 Table 74. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Application (2019-2024) & (USD Million)
 Table 75. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Application (2025-2030) & (USD Million)
 Table 76. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
 Table 77. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
 Table 78. Global Key Players of LV-Based Cell and Gene Therapy Products Upstream (Raw Materials)
 Table 79. Global LV-Based Cell and Gene Therapy Products Typical Customers


List of Figures
 Figure 1. LV-Based Cell and Gene Therapy Products Picture
 Figure 2. Global LV-Based Cell and Gene Therapy Products Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type in 2023
 Figure 4. CAR-T Therapy
 Figure 5. Autologous CD34+ Cell Gene Therapy
 Figure 6. Global LV-Based Cell and Gene Therapy Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application in 2023
 Figure 8. Hospital Picture
 Figure 9. Diagnostic and Testing Laboratories Picture
 Figure 10. Academic and Research Organizations Picture
 Figure 11. Others Picture
 Figure 12. Global LV-Based Cell and Gene Therapy Products Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 13. Global LV-Based Cell and Gene Therapy Products Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 14. Global Market LV-Based Cell and Gene Therapy Products Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 15. Global LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Region (2019-2030)
 Figure 16. Global LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Region in 2023
 Figure 17. North America LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 18. Europe LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 19. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 20. South America LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 21. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 22. Company Three Recent Developments and Future Plans
 Figure 23. Global LV-Based Cell and Gene Therapy Products Revenue Share by Players in 2023
 Figure 24. LV-Based Cell and Gene Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 25. Market Share of LV-Based Cell and Gene Therapy Products by Player Revenue in 2023
 Figure 26. Top 3 LV-Based Cell and Gene Therapy Products Players Market Share in 2023
 Figure 27. Top 6 LV-Based Cell and Gene Therapy Products Players Market Share in 2023
 Figure 28. Global LV-Based Cell and Gene Therapy Products Consumption Value Share by Type (2019-2024)
 Figure 29. Global LV-Based Cell and Gene Therapy Products Market Share Forecast by Type (2025-2030)
 Figure 30. Global LV-Based Cell and Gene Therapy Products Consumption Value Share by Application (2019-2024)
 Figure 31. Global LV-Based Cell and Gene Therapy Products Market Share Forecast by Application (2025-2030)
 Figure 32. North America LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type (2019-2030)
 Figure 33. North America LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application (2019-2030)
 Figure 34. North America LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 35. United States LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 36. Canada LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 37. Mexico LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 38. Europe LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type (2019-2030)
 Figure 39. Europe LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application (2019-2030)
 Figure 40. Europe LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 41. Germany LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 42. France LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 43. United Kingdom LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 44. Russia LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 45. Italy LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 46. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type (2019-2030)
 Figure 47. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application (2019-2030)
 Figure 48. Asia-Pacific LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Region (2019-2030)
 Figure 49. China LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 50. Japan LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 51. South Korea LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 52. India LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 53. Southeast Asia LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 54. Australia LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 55. South America LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type (2019-2030)
 Figure 56. South America LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application (2019-2030)
 Figure 57. South America LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 58. Brazil LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 59. Argentina LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 60. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Type (2019-2030)
 Figure 61. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Application (2019-2030)
 Figure 62. Middle East & Africa LV-Based Cell and Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
 Figure 63. Turkey LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 64. Saudi Arabia LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 65. UAE LV-Based Cell and Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
 Figure 66. LV-Based Cell and Gene Therapy Products Market Drivers
 Figure 67. LV-Based Cell and Gene Therapy Products Market Restraints
 Figure 68. LV-Based Cell and Gene Therapy Products Market Trends
 Figure 69. Porters Five Forces Analysis
 Figure 70. LV-Based Cell and Gene Therapy Products Industrial Chain
 Figure 71. Methodology
 Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Bluebird Bio
Thermo Fisher Scientific
Intas
BMS
Orchard Therapeutics

Related Reports

Global LV-Based Cell and Gene Therapy Products Supply, Demand and Key Producers, 2024-2030

Global LV-Based Cell and Gene Therapy Products Supply, Demand and Key Producers, 2024-2030

date 07 Apr 2024

date Medical Care

LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.

Product Tags

LV-Based Cell and Gene Therapy Products

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>